Tiemann Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-8,550
| Closed | -$240K | – | 212 |
|
|
2026
Q1 | $240K | Buy |
8,550
+500
| +6% | +$13.3K | 0.09% | 166 |
|
|
2025
Q4 | $200K | Sell |
8,050
-1,500
| -16% | -$37.8K | 0.08% | 192 |
|
|
2025
Q3 | $243K | Sell |
9,550
-500
| -5% | -$12.3K | 0.09% | 173 |
|
|
2025
Q2 | $244K | Buy |
10,050
+800
| +9% | +$18.7K | 0.1% | 160 |
|
|
2025
Q1 | $234K | Sell |
9,250
-900
| -9% | -$23.6K | 0.11% | 165 |
|
|
2024
Q4 | $269K | Sell |
10,150
-1,050
| -9% | -$28.5K | 0.12% | 153 |
|
|
2024
Q3 | $324K | Sell |
11,200
-650
| -5% | -$19K | 0.14% | 137 |
|
|
2024
Q2 | $332K | Sell |
11,850
-925
| -7% | -$25.5K | 0.15% | 126 |
|
|
2024
Q1 | $355K | Sell |
12,775
-550
| -4% | -$15.3K | 0.16% | 127 |
|
|
2023
Q4 | $384K | Buy |
13,325
+200
| +2% | +$6.05K | 0.19% | 110 |
|
|
2023
Q3 | $435K | Sell |
13,125
-700
| -5% | -$24.8K | 0.23% | 93 |
|
|
2023
Q2 | $507K | Sell |
13,825
-775
| -5% | -$30.2K | 0.26% | 84 |
|
|
2023
Q1 | $596K | Sell |
14,600
-1,103
| -7% | -$47.6K | 0.33% | 70 |
|
|
2022
Q4 | $805K | Buy |
15,703
+1,047
| +7% | +$50.2K | 0.47% | 53 |
|
|
2022
Q3 | $641K | Buy |
14,656
+200
| +1% | +$9.72K | 0.42% | 57 |
|
|
2022
Q2 | $758K | Sell |
14,456
-100
| -0.7% | -$5.1K | 0.4% | 63 |
|
|
2022
Q1 | $754K | Buy |
14,556
+1,300
| +10% | +$67.5K | 0.35% | 67 |
|
|
2021
Q4 | $783K | Buy |
13,256
+175
| +1% | +$8.67K | 0.33% | 72 |
|
|
2021
Q3 | $563K | Sell |
13,081
-325
| -2% | -$14.4K | 0.27% | 84 |
|
|
2021
Q2 | $525K | Buy |
13,406
+75
| +0.6% | +$2.92K | 0.25% | 97 |
|
|
2021
Q1 | $483K | Sell |
13,331
-350
| -3% | -$12.4K | 0.24% | 100 |
|
|
2020
Q4 | $504K | Buy |
13,681
+684
| +5% | +$25.1K | 0.27% | 93 |
|
|
2020
Q3 | $453K | Sell |
12,997
-158
| -1% | -$5.54K | 0.28% | 88 |
|
|
2020
Q2 | $408K | Buy |
13,155
+158
| +1% | +$5.37K | 0.28% | 87 |
|
|
2020
Q1 | $402K | Sell |
12,997
-26
| -0.2% | -$886 | 0.35% | 74 |
|
|
2019
Q4 | $484K | Sell |
13,023
-1,000
| -7% | -$35.6K | 0.33% | 79 |
|
|
2019
Q3 | $478K | Sell |
14,023
-1,766
| -11% | -$64.2K | 0.35% | 76 |
|
|
2019
Q2 | $649K | Buy |
15,789
+318
| +2% | +$12.6K | 0.47% | 59 |
|
|
2019
Q1 | $623K | Hold |
15,471
| – | – | 0.47% | 56 |
|
|
2018
Q4 | $641K | Sell |
15,471
-2,239
| -13% | -$92.9K | 0.57% | 53 |
|
|
2018
Q3 | $741K | Buy |
17,710
+210
| +1% | +$8.08K | 0.56% | 53 |
|
|
2018
Q2 | $602K | Hold |
17,500
| – | – | 0.48% | 58 |
|
|
2018
Q1 | $589K | Buy |
17,500
+686
| +4% | +$23.6K | 0.47% | 60 |
|
|
2017
Q4 | $578K | Buy |
16,814
+263
| +2% | +$8.97K | 0.46% | 63 |
|
|
2017
Q3 | $561K | Sell |
16,551
-237
| -1% | -$7.62K | 0.47% | 66 |
|
|
2017
Q2 | $535K | Sell |
16,788
-316
| -2% | -$9.96K | 0.48% | 64 |
|
|
2017
Q1 | $555K | Sell |
17,104
-220
| -1% | -$6.94K | 0.51% | 59 |
|
|
2016
Q4 | $534K | Sell |
17,324
-2,002
| -10% | -$61.1K | 0.52% | 62 |
|
|
2016
Q3 | $621K | Hold |
19,326
| – | – | 0.57% | 55 |
|
|
2016
Q2 | $646K | Buy |
19,326
+316
| +2% | +$10.1K | 0.61% | 53 |
|
|
2016
Q1 | $535K | Buy |
19,010
+949
| +5% | +$27.1K | 0.53% | 60 |
|
|
2015
Q4 | $553K | Sell |
18,061
-1,054
| -6% | -$33.2K | 0.56% | 57 |
|
|
2015
Q3 | $570K | Buy |
19,115
+1,795
| +10% | +$57.6K | 0.62% | 52 |
|
|
2015
Q2 | $551K | Buy |
17,320
+606
| +4% | +$19.8K | 0.56% | 60 |
|
|
2015
Q1 | $552K | Buy |
16,714
+437
| +3% | +$13.9K | 0.57% | 57 |
|
|
2014
Q4 | $481K | Sell |
16,277
-949
| -6% | -$27.2K | 0.52% | 62 |
|
|
2014
Q3 | $483K | Sell |
17,226
-1,159
| -6% | -$32.5K | 0.54% | 60 |
|
|
2014
Q2 | $518K | Sell |
18,385
-685
| -4% | -$19.5K | 0.57% | 59 |
|
|
2014
Q1 | $581K | Buy |
19,070
+685
| +4% | +$20.4K | 0.65% | 49 |
|
|
2013
Q4 | $534K | Buy |
+18,385
| New | +$535K | 0.63% | 54 |
|
Other funds holding PFE
Tiemann Investment Advisors's PFE Position: Q2 2026 in Review
Tiemann Investment Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,550 shares — an estimated $240K sold.
Tiemann Investment Advisors first reported a position in PFE in Q4 2013 and held it in 50 quarters. The position peaked at $805K in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Tiemann Investment Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Tiemann Investment Advisors sold 8,550 Pfizer shares in Q2 2026, an estimated $240K.
- Tiemann Investment Advisors first reported a position in Pfizer in Q4 2013 and held it in 50 quarters.
- Tiemann Investment Advisors's Pfizer position peaked at $805K in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Tiemann Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.